Drug Discovery Agent은(는) 안전한가요?

Drug Discovery Agent은(는) 안전한가요?

신뢰 점수 세부 정보 — Drug Discovery Agent has a Nerq Trust Score of 42.1/100 (E). Measured across 5 independent trust signals.

What Is Drug Discovery Agent?

Drug Discovery Agent is a software tool in the research category: AI-powered Drug Discovery Agent for real-time drug analysis and safety insights using Groq LLM, LangChain, and FastAPI.. Nerq Trust Score: 42/100 (E).

Nerq independently analyzes every software tool, app, and extension across multiple trust signals including 보안 vulnerabilities, 유지보수 activity, license 규정 준수, and 커뮤니티 채택.

How Nerq Assesses Drug Discovery Agent's Safety

Nerq's Trust Score is calculated from 13+ independent signals aggregated into five 차원. Here is how Drug Discovery Agent performs in each:

• 보안 (0/100): Drug Discovery Agent's 보안 posture is poor. This score factors in known CVEs, dependency vulnerabilities, 보안 policy presence, and code signing practices.
• 유지보수 (1/100): Drug Discovery Agent is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
• Documentation (1/100): Documentation quality is insufficient. This includes README completeness, API 문서화, usage examples, and contribution guidelines.
• Compliance (48/100): Drug Discovery Agent is 규정 준수 gaps exist. Assessed against regulations in 52 관할권s including the EU AI Act, CCPA, and GDPR.
• Community (0/100): Community adoption is limited. 기반: GitHub stars, forks, download counts, and ecosystem integrations.

The overall Trust Score of 42.1/100 (E) is the weighted combination of these measured signals. It is a measurement, not a pass/fail or suitability judgment — weigh the individual signals against your own requirements.

Who Typically Evaluates Drug Discovery Agent?

Drug Discovery Agent is commonly evaluated by:

• Developers and teams working with research tools
• Organizations evaluating AI tools for their stack
• Researchers exploring AI capabilities in this domain

How to read the signals: Drug Discovery Agent's measured signals (보안 0/100, 유지보수 1/100, 문서화 1/100, community 0/100) are shown above. These are measurements, not a suitability judgment — weigh each signal against the requirements of your own use case and risk tolerance.

How to Verify Drug Discovery Agent's Safety Yourself

While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:

1. Check the source code — 다음을 검토하세요: repository's 보안 policy, open issues, and recent commits for signs of active 유지보수.
2. Scan dependencies — Use tools like npm audit, pip-audit, or snyk to check for known vulnerabilities in Drug Discovery Agent's dependency tree.
3. 리뷰 permissions — Understand what access Drug Discovery Agent requires. Software tools should follow the principle of least privilege.
4. Test in isolation — Run Drug Discovery Agent in a sandboxed environment before granting access to production data or systems.
5. Monitor continuously — Use Nerq's API to set up automated trust checks: GET nerq.ai/v1/preflight?target=Drug-Discovery-Agent
6. 다음을 검토하세요: license — Confirm that Drug Discovery Agent's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
7. Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses 보안 concerns openly. Low community engagement may indicate limited peer review of the codebase.

Common Safety Concerns with Drug Discovery Agent

When evaluating whether Drug Discovery Agent is safe, consider these category-specific risks:

Drug Discovery Agent and the EU AI Act

Drug Discovery Agent is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.

Nerq's 규정 준수 assessment covers 52 관할권s worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal 규정 준수.

Best Practices for Using Drug Discovery Agent Safely

Whether you're an individual developer or an enterprise team, these practices will help you get the most from Drug Discovery Agent while minimizing risk:

Situations That Warrant 독립적 Review of Drug Discovery Agent

Nerq's signals are one input. In the following situations, evaluate Drug Discovery Agent's measured signals against your own requirements before making a decision:

• Environments handling sensitive or regulated data (healthcare, finance, government)
• Mission-critical systems where downtime has significant business impact
• Deployments with strict regulatory requirements that must be independently validated

For each situation, compare Drug Discovery Agent's measured trust score of 42.1/100 and its individual signals against your organization's own criteria. Nerq does not assert whether Drug Discovery Agent is suitable for any particular use.

How Drug Discovery Agent Compares to Industry Standards

Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among research tools, the average Trust Score is 62/100. Drug Discovery Agent's score of 42.1/100 is below the category average of 62/100.

This suggests that Drug Discovery Agent trails behind many comparable research tools. Organizations with strict 보안 requirements should evaluate whether higher-scoring alternatives better meet their needs.

Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks 보통 in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.

Trust Score History

Nerq continuously monitors Drug Discovery Agent and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or 유지보수 patterns change, Drug Discovery Agent's score is updated within 24 hours.

Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to 보안 and quality. Conversely, a downward trend may signal reduced 유지보수, growing technical debt, or unresolved vulnerabilities. To track Drug Discovery Agent's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=Drug-Discovery-Agent&include=history

Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — 보안, 유지보수, 문서화, 규정 준수, and community — has evolved independently, providing granular visibility into which aspects of Drug Discovery Agent are strengthening or weakening over time.

Drug Discovery Agent vs 대안

In the research category, Drug Discovery Agent scores 42.1/100. There are higher-scoring alternatives available. For a detailed comparison, see:

• Drug Discovery Agent vs gpt_academic — Trust Score: 60.9/100
• Drug Discovery Agent vs LlamaFactory — Trust Score: 79.7/100
• Drug Discovery Agent vs unsloth — Trust Score: 77.2/100

주요 요점

• Drug Discovery Agent has a measured Nerq Trust Score of 42.1/100 (E) — a composite of independent signals, not a suitability judgment.
• Among research tools, Drug Discovery Agent scores below the category average of 62/100 (a positional measurement relative to peers).
• The individual signals — 보안, 유지보수, 문서화, 규정 준수, community — are shown above. Weigh them against your own requirements.
• Query the current measured values via Nerq's Preflight API.